Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2017 18:45 ET | Source: Ascendis Pharma A/S

Ascendis Pharma A/S Announces Third Quarter 2017 Financial Results Conference Call on November 16

COPENHAGEN, Denmark, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet...
September 27, 2017 00:16 ET | Source: Ascendis Pharma A/S

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

COPENHAGEN, Denmark, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering...
September 26, 2017 08:00 ET | Source: Ascendis Pharma A/S

Ascendis Pharma A/S Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH

COPENHAGEN, Denmark, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet...